Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
917.96B
Market cap917.96B
Price-Earnings ratio
34.14
Price-Earnings ratio34.14
Dividend yield
0.66%
Dividend yield0.66%
Average volume
3.94M
Average volume3.94M
High today
$995.00
High today$995.00
Low today
$943.26
Low today$943.26
Open price
$949.00
Open price$949.00
Volume
1.54M
Volume1.54M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $974.75, giving the company a market capitalization of 917.96B. It carries a P/E multiple of 34.14 and pays a dividend yield of 65.7%.

On 2026-05-11, Eli Lilly(LLY) stock traded between a low of $943.26 and a high of $995.00. Shares are currently priced at $974.75, which is +3.3% above the low and -2.0% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.54M, compared to an average daily volume of 3.94M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

24/7 Wall St. 4h
Pfizer vs Eli Lilly: Different Bets on Pharma M&A

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . For a retirement-focused investor, on...

Pfizer vs Eli Lilly: Different Bets on Pharma M&A
TipRanks 5h
Why Eli Lilly’s Rival Novo Nordisk Stock Is Rising Today, 5/11/26

Shares in Novo Nordisk (NVO), the Danish pharma rival to U.S.-based Eli Lilly (LLY), rose roughly 3% in Monday’s pre-market trading. This comes as the Wegovy we...

Simply Wall St 6h
There's A Lot To Like About Eli Lilly's Upcoming US$1.73 Dividend

It looks like Eli Lilly and Company ( ) is about to go ex-dividend in the next three days. The ex-dividend date is usually set to be one business day before the...

There's A Lot To Like About Eli Lilly's Upcoming US$1.73 Dividend

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

TipRanks 2d
Insider Frenzy at JPMorgan, Chevron, Eli Lilly, Berkshire, Strategy

Insiders have been trading these 5 stocks: ((JPM)), ((CVX)), ((LLY)), (($BRK.B)) and ((MSTR)). Here is a breakdown of their recent trades and their value. Unlo...

Nasdaq 2d
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?

Key Points Eli Lilly and Novo Nordisk dominate the weight loss drug market with their injectable GLP-1 drugs. Both players recently won approval for oral form...

Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
Simply Wall St 3d
Eli Lilly Ramps Up US Growth Plans As Foundayo Risks Draw Focus

Eli Lilly (NYSE:LLY) has issued $9b in bonds to help fund nearly $15b of acquisitions and a large manufacturing buildout. The company is committing about $4.5b...

Eli Lilly Ramps Up US Growth Plans As Foundayo Risks Draw Focus
The Motley Fool 3d
Omada Health Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Sean Duffy President — Wei-Li Shao Chief Fina...

Omada Health Q1 2026 Earnings Transcript
Nasdaq 3d
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.

Key Points Eli Lilly's deep weight-management pipeline should allow it to remain the top player. The company could also make significant clinical progress els...

Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
Seeking Alpha 3d
Dividend Roundup: Eli Lilly, PepsiCo, Apple, Visa, and more

This week's dividend activity included increased payouts from Diamondback Energy (FANG) and PepsiCo (PEP) as well as declarations from companies such as Eli Lil...

Dividend Roundup: Eli Lilly, PepsiCo, Apple, Visa, and more
Investor's Business Daily 3d
Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off

Technology Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off Licensing Eli Lilly's new weight-loss drug is creat...

Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.